APA (7th ed.) Citation

Mitchell, L. G., Röshammar, D., Huang, F., Albisetti, M., Brandão, L. R., Bomgaars, L., . . . Brückmann, M. (2022). Anticoagulant effects of dabigatran on coagulation laboratory parameters in pediatric patients: Combined data from five pediatric clinical trials : stroke, systemic or venous thromboembolism. Thrombosis and haemostasis, 122(9), . https://doi.org/10.1055/s-0042-1744542

Chicago Style (17th ed.) Citation

Mitchell, Lesley G., et al. "Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials : Stroke, Systemic or Venous Thromboembolism." Thrombosis and Haemostasis 122, no. 9 (2022). https://doi.org/10.1055/s-0042-1744542.

MLA (9th ed.) Citation

Mitchell, Lesley G., et al. "Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials : Stroke, Systemic or Venous Thromboembolism." Thrombosis and Haemostasis, vol. 122, no. 9, 2022, https://doi.org/10.1055/s-0042-1744542.